BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12902884)

  • 1. Selection of patients with melanoma brain metastases for aggressive treatment.
    Harrison BE; Johnson JL; Clough RW; Halperin EC
    Am J Clin Oncol; 2003 Aug; 26(4):354-7. PubMed ID: 12902884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
    Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
    Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques.
    Paek SH; Audu PB; Sperling MR; Cho J; Andrews DW
    Neurosurgery; 2005 May; 56(5):1021-34; discussion 1021-34. PubMed ID: 15854250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.
    Videtic GM; Adelstein DJ; Mekhail TM; Rice TW; Stevens GH; Lee SY; Suh JH
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):240-3. PubMed ID: 17056192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
    Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
    Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CNS metastases in malignant melanomas].
    Willner J; Bohndorf W
    Strahlenther Onkol; 1995 Mar; 171(3):165-73. PubMed ID: 7709333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis.
    Kepka L; Cieslak E; Bujko K; Fijuth J; Wierzchowski M
    Acta Oncol; 2005; 44(4):389-98. PubMed ID: 16120548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
    Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
    Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity.
    Radbill AE; Fiveash JF; Falkenberg ET; Guthrie BL; Young PE; Meleth S; Markert JM
    Cancer; 2004 Aug; 101(4):825-33. PubMed ID: 15305416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.
    Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V
    Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
    Rades D; Haatanen T; Schild SE; Dunst J
    Cancer; 2007 Sep; 110(6):1345-50. PubMed ID: 17639588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.